| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |